Massey Challenge Expanding Across Virginia
The Massey Challenge is not over with the UKROP’S Monument Avenue 10k this year! There are three more partnership events throughout Virginia happening in April and May. This means Massey Challenge participants can continue to “make miles matter” through participation in more events! Visit www.run4massey.org to learn more and pick your Challenge.
Chat on colorectal cancer
In honor of Colorectal Cancer Awareness Month, ABC News National Health hosted a Twitter chat on the subject last week with everyone from clinicians to patients providing commentary. VCU Massey Cancer Center’s medical oncologist Khalid Matin, M.D., F.A.C.P., was able to answer questions and elaborate on the discussion topics posed by the moderator. An expert in gastrointestinal cancers, Matin is also the medical director of community oncology and clinical research affiliations at VCU Massey Cancer Center and an associate professor in the Division of Hematology, Oncology and Palliative Care in the Department of Internal Medicine at the VCU School of Medicine.
Community invited to a special preview and discussion of PBS documentary, CANCER: THE EMPEROR OF ALL MALADIES
Community Idea Stations’ WCVE PBS, the American Cancer Society and VCU Massey Cancer Center will host on March 23, 2015, a special preview and community discussion of the documentary, CANCER: THE EMPEROR OF ALL MALADIES. Local residents are invited to preview one hour of the upcoming six-hour PBS documentary and then engage in a discussion about cancer with local cancer researchers, doctors, advocates and a survivor.
National clinical trials offered at Massey utilize precision medicine aimed at improving treatment of early-stage lung cancer
VCU Massey Cancer Center is currently offering clinical trials for patients with early-stage lung cancer that utilize cutting-edge precision medicine techniques with the aim of improving treatment. This group of three integrated national clinical trials known as ALCHEMIST – Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials – use next-generation sequencing to identify patients with early-stage lung cancer whose tumors harbor specific and uncommon changes in two particular genes, epidermal growth factor receptor (EGFR) and anaplastic lymphoma receptor tyrosine kinase (ALK), thought to drive cancer growth.
Chat on the emotional side of healing
The Emotional Side of Healing was the subject of ABC News National Health’s weekly Twitter chat this past week, and patients, caregivers and clinicians were all asked to weigh-in on this area of interest. VCU Massey Cancer Center’s Egidio Del Fabbro, M.D., program director of palliative care, and Danielle Noreika, M.D., medical director of inpatient palliative care services, provided expert commentary as the moderator posed a series of questions and discussion topics.